Nurix Therapeutics, Inc. (NRIX) Insider Trading
Over the last 3 months, NRIX insiders made 0 open-market buys and 10 sales, a net sale of -$1.4M (SEC Form 4). Over the last 6 months, 170 institutions increased and 74 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
10
Net (3m)
-$1.4M
Insider trades by month Buys Sells
Jan
Feb
Mar
Apr
May
Jun
Context3-month price +56.5%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 25, 2026 | Ring Christineofficer: Chief Legal Officer | Option | 13,333 | $7.26 |
| Jun 25, 2026 | Ring Christineofficer: Chief Legal Officer | Option | 15,602 | $8.72 |
| Jun 25, 2026 | Ring Christineofficer: Chief Legal Officer | Sell | 28,935 | $20.06 |
| Jun 25, 2026 | Hansen Gwennofficer: Chief Scientific Officer | Sell | 5,394 | $20.00 |
| Jun 2, 2026 | Ring Christineofficer: Chief Legal Officer | Sell | 8,148 | $16.60 |
| Jun 2, 2026 | Ring Christineofficer: Chief Legal Officer | Option | 3,422 | $1.86 |
| May 15, 2026 | Reinsdorf Judith Adirector | Grant | 31,250 | $15.86 |
| May 15, 2026 | DANSEY ROGER Ddirector | Grant | 31,250 | $15.86 |
| May 15, 2026 | Kapur Anildirector | Grant | 31,250 | $15.86 |
| May 15, 2026 | GREGORY JULIA Pdirector | Grant | 31,250 | $15.86 |
| May 15, 2026 | Lacey David L.director | Grant | 31,250 | $15.86 |
| May 15, 2026 | Baynes Roy D.director | Grant | 31,250 | $15.86 |
| May 15, 2026 | Silva Paul Mdirector | Grant | 31,250 | $15.86 |
| May 15, 2026 | Saltzman Edward Cdirector | Grant | 31,250 | $15.86 |
| May 5, 2026 | van Houte Hansofficer: Chief Financial Officer | Sell | 582 | $17.18 |
| May 5, 2026 | van Houte Hansofficer: Chief Financial Officer | Sell | 13,473 | $16.58 |
| May 4, 2026 | Ring Christineofficer: Chief Legal Officer | Sell | 8,148 | $16.96 |
| May 1, 2026 | Ring Christineofficer: Chief Legal Officer | Sell | 5,394 | $16.76 |
| Apr 30, 2026 | van Houte Hansofficer: Chief Financial Officer | Sell | 2,388 | $16.65 |
| Apr 30, 2026 | Hansen Gwennofficer: Chief Scientific Officer | Sell | 3,214 | $16.65 |
| Apr 30, 2026 | Ring Christineofficer: Chief Legal Officer | Option | 2,858 | — |
| Apr 30, 2026 | Hansen Gwennofficer: Chief Scientific Officer | Option | 2,858 | — |
| Apr 30, 2026 | van Houte Hansofficer: Chief Financial Officer | Option | 2,858 | — |
| Apr 30, 2026 | Ring Christineofficer: Chief Legal Officer | Sell | 3,214 | $16.65 |
| Apr 30, 2026 | van Houte Hansofficer: Chief Financial Officer | Option | 2,000 | — |
| Apr 30, 2026 | Hansen Gwennofficer: Chief Scientific Officer | Option | 3,750 | — |
| Apr 30, 2026 | van Houte Hansofficer: Chief Financial Officer | Option | 3,750 | — |
| Apr 30, 2026 | Ring Christineofficer: Chief Legal Officer | Option | 2,000 | — |
| Apr 30, 2026 | Ring Christineofficer: Chief Legal Officer | Option | 3,750 | — |
| Apr 30, 2026 | Hansen Gwennofficer: Chief Scientific Officer | Option | 2,000 | — |
Source: NRIX SEC Form 4 filings, latest Jun 25, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their NRIX positions over the last 6 months (SEC Form 13F).
Increased
170
New positions
75
Reduced
74
Sold out
55
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 8.9M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 8.9M | Feb 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 8.9M | May 15, 2026 |
| REDMILE GROUP, LLC | Increased | 8.1M | Feb 17, 2026 |
| REDMILE GROUP, LLC | Reduced | 7.7M | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | Increased | 7.4M | May 29, 2026 |
| DEEP TRACK CAPITAL, LP | Increased | 7.0M | Feb 13, 2026 |
| VESTAL POINT CAPITAL, LP | Increased | 6.5M | May 15, 2026 |
| DEEP TRACK CAPITAL, LP | Reduced | 6.3M | May 15, 2026 |
| VANGUARD GROUP INC | Increased | 5.9M | Jan 29, 2026 |
| FMR LLC | Increased | 5.5M | May 15, 2026 |
| STATE STREET CORP | Increased | 5.1M | May 15, 2026 |
| MORGAN STANLEY | Reduced | 4.9M | May 15, 2026 |
| GENERAL ATLANTIC, L.P. | New Position | 4.9M | Feb 17, 2026 |
| MORGAN STANLEY | Increased | 4.9M | Feb 13, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.